Phase I/II study protocol to assess safety and efficacy of adoptive cell therapy with anti-PD-1 plus low-dose pegylated-interferon-alpha in patients with metastatic melanoma refractory to standard of care treatments: the ACTME trial
| Image |  |
|---|---|
| Description | scientific article published on 24 November 2020 |
| Author/s |
author: Ellen Kapiteijn Sjoerd H van der Burg Monique K van der Kooij |
| Publication date | November 24, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |